Please assess the completion status of the following clinical trial:

Trial Title: Certoparin in Renal Patients Undergoing Hemodialysis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients requiring hemodialysis~* Patients requiring anticoagulation therapy during hemodialysis~* Written informed consent~Exclusion Criteria:~* Hypersensitivity to study medication~* Genetic abnormality or disease of clotting system~* Prior major surgery or bleeding~* Other protocol-defined inclusion/exclusion criteria may apply

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Certoparin (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).